Search This Blog

Wednesday, February 5, 2025

Tariff Threat Spurs Canada to Rethink Limits on Oil Pipelines

 Almost every day since the expansion of Canada’s Trans Mountain pipeline was completed in May, a tanker laden with oil sands crude shipped through the line has passed under Vancouver’s Lions Gate Bridge en route to refineries around the Pacific.

Those tankers, bound for China and Japan among other markets, mark a significant shift for Canada, which has long been stuck exporting its vast flows of oil solely to the US. And with President Donald Trump’s tariff threats highlighting the risk of that dependence, the success of the C$34 billion ($24 billion) Trans Mountain expansion is stoking Canada’s desire to further decouple from its unpredictable neighbor — and play a larger role in global oil markets.

Trans Mountain “is a good start,” said Adam Waterous, a former investment banker and the founder and chairman of oil producer Strathcona Resources Ltd. “Now we have to build on it. The very fortunate thing is that we’re not starting from scratch.”

Canada’s oil industry has long pushed for more pipelines, both to its own coasts and to the US, only to see them thwarted by opposition from environmental groups, Indigenous communities and courts as well as the country’s own federal and provincial governments.

But those efforts are garnering renewed interest as Canadians reel from Trump’s trade attack, an episode that has sparked anger and distrust at the country’s southern neighbor, even pushing hockey fans to go so far as to boo the US national anthem at recent games.

Two mothballed projects in particular are being discussed as ripe for revival: Energy East, which would carry western Canadian crude east to refineries in Ontario and Quebec; and Northern Gateway, which would haul Alberta oil to a Pacific port in northern British Columbia.

Energy East would have converted an existing natural gas pipeline to carry about 1.1 million barrels of oil a day from Alberta and Saskatchewan to refineries and a shipping terminal in eastern Canada. Crucially, that would avoid moving crude through the US, as is done on Enbridge Inc.’s Line 5, which crosses the border on its route to Ontario and Quebec.


“Everybody is of the view that we have to rethink a little bit some of the vulnerabilities we’ve got, vis-a-vis the United States,” Natural Resources Minister Jonathan Wilkinson said in an interview.

Northern Gateway was halted by a court in 2016 amid objections from environmental groups and First Nations, and it was later rejected by Canadian Prime Minister Justin Trudeau in 2016. The roughly 1,178-kilometer (732-mile) line would have run from Alberta to Kitimat, British Columbia, with a capacity of 525,000 barrels a day, providing oil sands producers with a way to send more crude to buyers in Asia.

Canada’s government should declare an energy emergency to streamline the regulatory process for Energy East and Northern Gateway, start building them in the coming months and complete them while Trump is still in office, Strathcona’s Waterous said.

“Canada, when in a time of national need, can construct nation-building projects,” Waterous said. “There’s no question that this is a time now of national need.”

Enbridge said Monday it has no plans to develop Northern Gateway and is instead focusing on increasing capacity on pipelines it already has in place. South Bow Corp., the oil pipeline company spun out of former Energy East proponent TC Energy Corp., declined to comment on Energy East. TC Energy didn’t immediately respond to a request for comment.

Even with company support, new pipelines would likely take years and billions of dollars to build. The cost of the Trans Mountain expansion, which nearly tripled the line’s capacity to 890,000 barrels a day, ballooned more than sixfold by the time it was completed. That bill was largely footed by Canadian taxpayers because Trudeau’s government bought the line in 2018 to save it from cancellation by original proponent Kinder Morgan.

That’s not to mention the opposition the lines would continue to face from environmentalists.

“This is a very old playbook, where the oil industry is looking to take advantage of a crisis to brush aside environmental and health protections,” Keith Stewart, senior energy strategist with Greenpeace Canada, said in an email.

With all those hurdles, one of the quickest and easiest solutions for Canadian oil producers may lie in further expanding Trans Mountain. The system is currently only shipping about 720,000 barrels a day, about 80% of its projected capacity, because high tolls to pay for its costly completion are making spot shipments uneconomical.

Trans Mountain’s capacity could be expanded by 200,000 to 300,000 barrels a day by boosting pumping power, executives have said.

The dock at the terminus of Trans Mountain is now shipping as many as 480,000 barrels a day, but may approach its slated capacity of about 630,000 barrels a day by mid-year after port authorities add navigational aids that will allow ships into the port at night. Volumes beyond the dock’s capacity largely flow into Washington State through connected pipelines

Even below its capacity, Trans Mountain is reshaping the global oil market. China is buying increasing amounts of Canadian crude, supplanting purchases from sanctioned countries including Iran and Russia. That’s also pressuring prices of Middle Eastern and Latin American crudes similar to Canada’s heavy oil. Meanwhile, Canadian oil prices had risen and steadied, at least until the tariff threats began.

“The pull from the Asian markets will be there,” Trans Mountain Corp. Chief Executive Officer Mark Maki said in an interview. “We should be exploring opportunities to add value to the system.”


https://finance.yahoo.com/news/canada-eyes-more-ways-ship-130000314.html

'USPS reverses decision to suspend inbound packages from China, Hong Kong'

 The U.S. Postal Service (USPS) on Wednesday said it will accept inbound mail and packages from China and Hong Kong, reversing a decision made hours earlier. 

"The USPS and Customs and Border Protection are working closely together to implement an efficient collection mechanism for the new China tariffs to ensure the least disruption to package delivery," USPS said in a statement. 

The reversal came less than 24 hours after the agency temporarily suspended international package acceptance of inbound parcels from China and Hong Kong Posts "until further notice."

The Tuesday package suspension announcement came as China issued retaliatory tariffs on select American imports. 

The Chinese government said it would take "necessary countermeasures" in response to President Donald Trump’s executive order imposing a 10% tariff on Chinese imports to address what the White House says is the synthetic opioid supply chain in China. Trump temporarily paused planned tariffs on Mexico and Canada for 30 days to give both nations time to reach a deal with the U.S. to better secure its northern and southern borders.

The order accused the Chinese Communist Party of having "subsidized and otherwise incentivized" Chinese chemical companies to export fentanyl and related precursor chemicals that are used to produce synthetic opioids sold illicitly in the U.S.

"The orders make clear that the flow of contraband drugs like fentanyl to the United States, through illicit distribution networks, has created a national emergency, including a public health crisis. Chinese officials have failed to take the actions necessary to stem the flow of precursor chemicals to known criminal cartels and shut down money laundering by transnational criminal organizations," the White House said on Saturday.  

Fetanyl Pills

The investigation resulted in the seizure of about 32,000 fentanyl pills with a street value of $1 million. (NYC Special Narcotics Prosecutor's Office / Fox News)

The Ministry of Foreign Affairs of The People’s Republic of China said in a statement that "the U.S.’s tariff hikes "severely violate" the World Trade Organization rules and that this "move cannot solve the U.S.'s problems at home and more importantly, does not benefit either side, still less the world." 

After China banned the production of fentanyl in 2019, China-based companies started to produce and sell fentanyl precursors, which are the ingredients needed to manufacture the drug, according to the United States Drug Enforcement Administration (DEA). 

At least two cartels in Mexico – the Sinaloa cartel based in Sinaloa and cartel Jalisco Nueva Generación based in Jalisco – receive fentanyl precursors and synthetic opioids directly from China or from intermediaries in the U.S., according to the DEA. They maintain distribution hubs in various cities across the U.S. and control smuggling corridors into the country, the agency said.

Fentanyl can be 50 times more potent than heroin in small amounts. Overdose deaths involving synthetic opioids – primarily illicitly manufactured fentanyl – rose to 73,838 in 2022, according to the latest data from the National Institute on Drug Abuse.

https://www.foxbusiness.com/economy/usps-reverses-decision-suspend-inbound-packages-from-china-hong-kong

Court Denies Apple's Request To Intervene In Google Search Monopoly Case

 by Naveen Athrappully via The Epoch Times,

Apple’s attempt to intervene in litigation related to Google’s search engine monopoly was denied by a district court on Sunday when a judge refused to stay the remedial proceedings in the case.

Back in October 2020, the U.S. Department of Justice (DOJ) and a coalition of state attorneys filed a case against Google, accusing the tech company of engaging in anti-competitive practices.

Google was accused of establishing exclusive agreements with browser developers, mobile device manufacturers, and wireless carriers which prohibited them from pre-installing rival search engines. This resulted in most U.S. devices coming preloaded with Google search, negatively affecting competitors in the market.

In August 2024, Judge Amit Mehta from the U.S. District Court for the District of Columbia sided with the plaintiffs, ruling that Google violated antitrust laws.

“Google is a monopolist, and it has acted as one to maintain its monopoly,” he wrote, saying that the default search engine setting “is extremely valuable real estate.”

A hearing on remedies in the case was scheduled for April 2025.

In December, Apple filed a motion to intervene as a defendant in the case, aiming to take part in the remedial phase of the litigation. However, the motion was denied by Mehta, who called the request “untimely.”

Apple then filed an emergency motion seeking to stay the remedial proceedings pending its appeal of Mehta’s order denying the intervention request. On Feb. 2, Mehta denied the stay request as well.

“First, Apple has not established a likelihood of success on the merits” for the stay, Mehta wrote.

The company also failed to show it stands to suffer “irreparable harm absent a stay,” he said.

“Because Apple has not satisfied the ‘stringent requirements’ for obtaining the ‘extraordinary relief’ of a stay pending appeal, its motion is denied.”

Apple claims the December motion was filed to protect the company’s existing contract with Google and its ability to enter into future contracts with the search engine giant.

Google pays the company to keep its search engine default on Apple’s Safari mobile and desktop browsers, according to a court document from the August 2024 monopoly decision.

“In 2022, Google’s revenue share payment to Apple was an estimated $20 billion,” said the document.

“This is nearly double the payment made in 2020, which was then equivalent to 17.5 percent of Apple’s operating profit.”

Meanwhile, a potential breakup of Google’s business could be on the cards during the remedy phase of the litigation.

In November, the DOJ together with 38 states and territories outlined a proposed remedy that would force Google to divest its Chrome browser.

Regulators argued that Google uses the browser to reinforce its monopoly.

At the time, the government was reportedly looking at potential divestiture of Google’s Android operating system.

Google opposed these suggestions, saying the forced sale of Chrome and Android would “endanger the security and privacy of millions of Americans, and undermine the quality of products people love.”

The move may end up chilling the company’s investment in artificial intelligence, it said.

The Epoch Times reached out to Google and Apple for comment on the recent ruling.

https://www.zerohedge.com/markets/court-denies-apples-request-intervene-google-search-monopoly-case

Politico, NY Times Propped Up By Millions Of Dollars From US Government

 On Tuesday, staffers at Politico were notified that a 'technical error' had prevented paychecks from going out. Many joked that this had something to do with the Trump administration putting a freeze on USAID funding.

And while there's no evidence the two are linked, the suggestion prompted internet sleuths to look into Politico's sources of funding. What they found was absolutely shocking.

According to government spending tracker website USASPENDING.govPolitico - which laundered the Hunter Biden '51 intel officials' propaganda during the 2020 election - received up to $27 million (and by some counts $32 million) from various US agencies during the Biden years.

In one instance, roughly $500,000 was spent on 37 Politico 'pro' subscriptions.

Of note, Politico was sold to German media giant Axel Springer (which also owns Business Insider) for $1 billion in 2021, meaning US taxpayer dollars have been flowing to the German media giant to prop up their US propaganda rags.

And look at this, the NY Times received $3.1 million in taxpayer funds, while the UK's BBC received $3.2 million.

Cumberland reports data from trial of ifetroban for Duchenne

 Cumberland Pharmaceuticals has reported positive top-line outcomes from a Phase II trial of ifetroban as a potential treatment for Duchenne muscular dystrophy (DMD).

A total of 41 subjects with DMD were enrolled in the double-blind, placebo-controlled FIGHT DMD trial, which lasted 12 months.

Subjects received either a daily dose of either 100mg (low dose) or 300mg (high dose) of the oral thromboxane receptor antagonist ifetroban or a placebo.

Improvement in the heart's left ventricular ejection fraction (LVEF) was the trial's primary endpoint.

The results showed that high-dose treatment of the therapy led to a 3.3% overall improvement in LVEF.

The high-dose arm experienced a 1.8% increase in LVEF, against a 1.5% decline in the placebo arm.

Compared with propensity-matched natural history controls, the high-dose treatment showed an overall improvement of 5.4%, as control subjects reported a decline of 3.6% in LVEF.

Both doses of the therapy were observed to be well-tolerated, without any serious drug-related events.

Ifetroban functions by blocking a receptor involved in inflammation and fibrosis, and has received orphan drug and rare paediatric disease statuses from the Food and Drug Administration (FDA).

If approved, the drug is expected to become the first therapy specifically indicated for DMD-related heart disease.

Cumberland Pharmaceuticals CEO AJ Kazimi said: “As the first company to receive FDA orphan products development funding for a DMD clinical trial, we're honoured to be advancing a potential breakthrough therapy for DMD-related heart disease.

“These results validate our commitment to developing innovative treatments for rare diseases and underscore the importance of collaborative partnerships between industry, academia, and regulatory agencies in addressing critical unmet medical needs.”

Based in Tennessee, Cumberland Pharmaceuticals develops, acquires and commercialises products for hospital acute care, gastroenterology and oncology.

In May 2023, the company announced plans to launch the Phase II FIGHTING FIBROSIS trial of ifetroban for idiopathic pulmonary fibrosis (IPF).


https://finance.yahoo.com/news/cumberland-pharmaceuticals-reports-data-trial-102306151.html

Pasithea Positive Safety Review in ongoing Phase 1 Trial of Cancer Candidate

 

  • SRC recommended that the trial escalate to the next dose level of 22mg capsule
  • No dose-limiting toxicities (DLT’s) or rash observed to date in either capsule or tablet formulations

US drafts plan to withdraw all its troops from Syria: report

 The US Department of Defense is developing plans to withdraw all US troops from Syria, NBC News reported on Wednesday, citing two US defense officials.

President Donald Trump and officials close to him recently expressed interest in pulling US troops out of Syria, leading Pentagon officials to begin drawing up plans for a full withdrawal in 30, 60 or 90 days, the report added.

https://nypost.com/2025/02/05/us-news/us-drafts-plan-to-withdraw-troops-from-syria/